Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Current Leases (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Current Leases data on record, last reported at $159000.0 in Q3 2025.

  • For Q3 2025, Current Leases fell 42.18% year-over-year to $159000.0; the TTM value through Sep 2025 reached $159000.0, down 42.18%, while the annual FY2024 figure was $274000.0, 1.48% up from the prior year.
  • Current Leases reached $159000.0 in Q3 2025 per TNXP's latest filing, down from $195000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $438000.0 in Q1 2023 and bottomed at $159000.0 in Q3 2025.
  • Average Current Leases over 3 years is $297272.7, with a median of $275000.0 recorded in 2024.
  • Peak YoY movement for Current Leases: increased 1.48% in 2024, then tumbled 42.18% in 2025.
  • A 3-year view of Current Leases shows it stood at $270000.0 in 2023, then rose by 1.48% to $274000.0 in 2024, then crashed by 41.97% to $159000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $159000.0 in Q3 2025, $195000.0 in Q2 2025, and $235000.0 in Q1 2025.